Paul Sugarbaker
{{BLP sources|date=November 2018}}
Paul Hendrick Sugarbaker (born November 28, 1941, in Baltimore) is an American surgeon at the Washington Cancer Institute. He is known for developments in surgical oncology of the abdomen, including cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy,{{Cite journal|last1=Neuwirth|first1=Madalyn G.|last2=Alexander|first2=H. Richard|last3=Karakousis|first3=Giorgos C.|date=February 1, 2016|title=Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective |journal=Journal of Gastrointestinal Oncology|volume=7|issue=1|pages=18–28|issn=2078-6891|pmc=4754315|pmid=26941981|doi=10.3978/j.issn.2078-6891.2015.106}} or HIPEC, a treatment alternately referred to as the Sugarbaker Procedure.{{Cite news|url=https://www.nytimes.com/2011/08/12/business/heated-chemotherapy-bath-may-be-only-hope-for-some-cancer-patients.html|title=Heated, Harrowing Chemotherapy Bath May Be Only Hope for Some|last=Pollack|first=Andrew|date=2011-08-11|work=The New York Times|access-date=2018-04-22|language=en-US|issn=0362-4331}}{{Cite news|url=https://www.washingtonpost.com/lifestyle/style/surgeon-performs-controversial-cancer-surgery-named-after-him/2012/11/25/c8ad7ab8-29da-11e2-bab2-eda299503684_story.html|title=Surgeon performs controversial cancer surgery named after him|last=Wilber|first=Del Quentin|date=2012-11-25|newspaper=Washington Post|access-date=2018-04-22|language=en-US|issn=0190-8286}}
Sugarbaker is the elder brother of the surgeon David Sugarbaker.{{cite journal |last1=Coselli |first1=Joseph S. |title=In Memoriam: David J. Sugarbaker, MD (1953–2018) |journal=Texas Heart Institute Journal |date=2019 |volume=46 |issue=1 |pages=1–2 |pmc=6379011 |doi=10.14503/THIJ-18-6879 }} Sugarbaker attended high school in Jefferson City, Missouri and received a bachelor's degree from Wheaton College in Illinois in 1963. In 1967 he graduated from the medical college at Cornell University. He interned and did his residency at Peter Bent Brigham Hospital in Boston, serving as chief resident from 1973 to 1976. From 1976 to 1986, he spent ten years at the National Cancer Institute–Surgery Branch of the National Institutes of Health in Bethesda, Maryland, as Senior Investigator.{{Cite web|url=http://www.sugarbakeroncology.com/|title=Sugarbaker Oncology Associates {{!}} Home Page|website=Sugarbaker Oncology Associates|language=en-US|access-date=2019-01-28}} He was also head of surgical oncology at Emory University Medical School, and the medical director of surgical oncology at the Washington Cancer Institute at the MedStar Washington Hospital Center.
Ovarian cancer
Among patients with stage III epithelial ovarian cancer, the addition of HIPEC to interval cytoreductive surgery resulted in longer recurrence-free survival and overall survival than surgery alone and did not result in higher rates of side effects.{{Cite journal|last1=van Driel|first1=Willemien J.|last2=Koole|first2=Simone N.|last3=Sikorska|first3=Karolina|last4=Schagen van Leeuwen|first4=Jules H.|last5=Schreuder|first5=Henk W.R.|last6=Hermans|first6=Ralph H.M.|last7=de Hingh|first7=Ignace H.J.T.|last8=van der Velden|first8=Jacobus|last9=Arts|first9=Henriëtte J.|date=2018-01-18|title=Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer|journal=New England Journal of Medicine|language=en|volume=378|issue=3|pages=230–240|doi=10.1056/nejmoa1708618|pmid=29342393|issn=0028-4793|hdl=1874/364110|doi-access=free|hdl-access=free}}
References
{{reflist}}
{{Authority control}}
{{DEFAULTSORT:Sugarbaker, Paul}}